Cardiovascular and sedation reversal effects of intramuscular administration of atipamezole in dogs treated with medetomidine hydrochloride with or without the peripheral α2-adrenoceptor antagonist vatinoxan hydrochloride

Heta Turunen,Marja Raekallio,Juhana Honkavaara,Flavia Restitutti,Ira Janika Kallio-Kujala,Magdy Adam,Katri Nevanperä,Mika Scheinin,Sofia Männikkö,Heidi Hautajärvi,Paula Larenza-Menzies,Outi Vainio

Cardiovascular and sedation reversal effects of intramuscular administration of atipamezole in dogs treated with medetomidine hydrochloride with or without the peripheral α2-adrenoceptor antagonist vatinoxan hydrochloride

2019

Heta Turunen
Marja Raekallio
Juhana Honkavaara
Flavia Restitutti
Ira Janika Kallio-Kujala
Magdy Adam
Katri Nevanperä
Mika Scheinin
Sofia Männikkö
Heidi Hautajärvi
Paula Larenza-Menzies
Outi Vainio

OBJECTIVE To investigate the cardiovascular and sedation reversal effects of IM administration of atipamezole (AA) in dogs treated with medetomidine hydrochloride (MED) or MED and vatinoxan (MK-467...

Keywords:

Antagonist
Medetomidine hydrochloride
Hydrochloride
Anesthesia
Adrenergic receptor
Atipamezole
Immunology
Sedation
Biology
Peripheral
Pharmacokinetics
Receptor antagonist

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations